Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful long-term systemic sclerosis treatment by high-frequent low-dose B cell-depleting therapy.
Moazedi-Fuerst FC, Lackner A, Kreuzer SM, Eller K, Odler B, Kovacs G, Flick H, Talakic E, Hermann J, Venhoff N, Venhoff A, Hafner F, Brodmann M, Jud P, Yazdani-Biuki B, Husic R, Salmhofer W, Stradner MH, Graninger WB, Thiel J, Brezinschek HP. Moazedi-Fuerst FC, et al. Among authors: venhoff n. J Autoimmun. 2024 Jul;147:103246. doi: 10.1016/j.jaut.2024.103246. Epub 2024 May 23. J Autoimmun. 2024. PMID: 38788540 Free article.
Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial.
Venhoff N, Schmidt WA, Bergner R, Rech J, Unger L, Tony HP, Finzel S, Andreica I, Kofler DM, Weiner SM, Lamprecht P, Schulze-Koops H, App C, Pournara E, Mendelson MH, Sieder C, Maricos M, Thiel J. Venhoff N, et al. Lancet Rheumatol. 2023 Jun;5(6):e341-e350. doi: 10.1016/S2665-9913(23)00101-7. Lancet Rheumatol. 2023. PMID: 38251601 Clinical Trial.
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
Rech J, Tascilar K, Hagen M, Kleyer A, Manger B, Schoenau V, Hueber AJ, Kleinert S, Baraliakos X, Braun J, Kiltz U, Fleck M, Rubbert-Roth A, Kofler DM, Behrens F, Feuchtenberger M, Zaenker M, Voll R, Venhoff N, Thiel J, Glaser C, Feist E, Burmester GR, Karberg K, Strunk J, Cañete JD, Senolt L, Filkova M, Naredo E, Largo R, Krönke G, D'Agostino MA, Østergaard M, Schett G. Rech J, et al. Among authors: venhoff n. Lancet. 2024 Mar 2;403(10429):850-859. doi: 10.1016/S0140-6736(23)02650-8. Epub 2024 Feb 13. Lancet. 2024. PMID: 38364841 Clinical Trial.
Amphiphysin and GAD65 IgG antibodies in patients with obsessive-compulsive syndromes.
von Zedtwitz K, Feige B, Maier A, Schaefer SL, Nickel K, Reisert M, Spiegelhalder K, Venhoff N, Brumberg J, Urbach H, Dersch R, Schiele MA, Domschke K, Tebartz van Elst L, Coenen VA, Hannibal L, Prüss H, Maier SJ, Endres D. von Zedtwitz K, et al. Among authors: venhoff n. Eur Neuropsychopharmacol. 2025 Jan;90:80-82. doi: 10.1016/j.euroneuro.2024.10.005. Epub 2024 Nov 30. Eur Neuropsychopharmacol. 2025. PMID: 39616701 No abstract available.
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors.
Sorin B, Papo M, Sinico RA, Teixeira VS, Venhoff N, Urban ML, Iudici M, Mahrhold J, Locatelli F, Cassone G, Schiavon F, Seeliger B, Neumann T, Feder C, Kroegel C, Groh M, Marvisi C, Samson M, Barba T, Jayne D, Troilo A, Thiel J, Hellmich B, Monti S, Montecucco C, Salvarani C, Kahn JE, Bonnotte B, Durel CA, Puéchal X, Mouthon L, Guillevin L, Emmi G, Vaglio A, Porcher R, Terrier B. Sorin B, et al. Among authors: venhoff n. J Autoimmun. 2024 Dec;149:103338. doi: 10.1016/j.jaut.2024.103338. Epub 2024 Nov 16. J Autoimmun. 2024. PMID: 39549485
[News on the treatment of large vessel vasculitis].
Venhoff N, Zeisbrich M. Venhoff N, et al. Z Rheumatol. 2024 Dec;83(10):812-821. doi: 10.1007/s00393-024-01563-2. Epub 2024 Sep 20. Z Rheumatol. 2024. PMID: 39302435 Review. German.
141 results